Overview

A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Alcon Research
Treatments:
Brinzolamide
Timolol
Criteria
Inclusion Criteria:

- Adults of either sex and any race diagnosed with open-angle glaucoma (with or without
pseudoexfoliation or pigment dispersion component)

Exclusion Criteria:

- Under 18